- Not Fee assured
- Awaiting verification
- Open Referral network
Offers
- Face-to-face consultations
- Home chemotherapy
About me
Chris Parker qualified from Oxford University in 1989. He has been a consultant oncologist, specialising in prostate cancer at the Royal Marsden Hospital since 2001. He has published over 300 articles on prostate cancer and is former chair of the National Cancer Research Institute Prostate Cancer Clinical Studies Group.
Areas of interest
Prostate cancer; radiotherapy; hormone therapy; chemotherapy; active surveillance; radionuclide therapy
Medical secretaries
- MedSec.Urology@rmh.nhs.uk
- 020 8661 3269
- MedSec.Urology@rmh.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
-
X6740
Preparation for simple radiotherapy with imaging, dosimetry and simple calculation - (5-50)
The Royal Marsden Hospital (5-50)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
-
X6549
Delivery of a fraction of complex radiotherapy with intensity modulated radiotherapy (IMRT) - (1-5)
- Show All (7 )...